On July 11, 2012, Merus Labs International Inc. acquired Emselex®/Enablex®. Stewart Muglich and Victor Dudas of our Corporate Finance & Securities Group handled the debt facility between Merus and PDL BioPharma Inc., a company that supports the healthcare industry with creative financing solutions, assisted by Amaan Gangji and Kevin MacDonald. The transaction involved counsel from Toronto, New York, Switzerland, the Netherlands and Luxembourg.
Related Content
Clark Wilson acts for PIRET in closing $143.8 million bought deal
Clark Wilson acted for Pure Industrial Real Estate Trust (PIRET) (TSX: AAR.UN) in closing its public offering of 26,875,500 trust units, on a bought deal ... Continued
Testamentary Trust Proposals: Not Much of a Consultation
Discussion on the testamentary trust consultation paper relased on June 3, 2013
BC Court of Appeal Clarifies Law concerning Constructive Trust as a Remedy
With the evolving complexity of fraudulent schemes, justice requires flexible remedies for victims to address novel situations. The recent British Columbia Court of Appeal decision ... Continued